Heartbeam Inc gains on U.S. patent for heart device

Heartbeam

28/09/2022 17:24

** Medical device maker Heartbeam Inc's shares  BEAT.O 
climb 10.5% to $2.97, on track for fifth straight session of
gains 
    ** Co receives U.S. patent providing intellectual property
protection for its HeartBeam AIMIGo technology, intended to help
physicians identify a heart attack  urn:newsml:reuters.com:*:nBw6SRjDSa
    ** The credit-card size device allows patients to record a
set of signals outside of a medical setting with an
electrocardiogram that is immediately transmitted to a physician
for review and diagnosis
    ** This is co's second patent received this month; co was
granted U.S. patent for ECG patch monitor on Sept.
15 urn:newsml:reuters.com:*:nL4N30M2X2
    ** Including session's gains, stock had fallen 3% YTD
compared with a 29.8% decline in the Nasdaq composite index
 .IXIC 
 (Reporting by Shristi  Achar A)
 ((Shristi.AcharA@thomsonreuters.com;))